1 FTSE 100 stock investors might shun, but I’d snap up in a heartbeat!

Some FTSE 100 stocks have fallen foul of investors. However, that doesn’t mean they’re not good investments for me and my holdings.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

A handsome mature bald bearded black man in a sunglasses and a fashionable blue or teal costume with a tie is standing in front of a wall made of striped wooden timbers and fastening a suit button

Image source: Getty Images

FTSE 100 stalwart British American Tobacco (LSE: BATS) isn’t everybody’s cup of tea. This is for reasons that may be obvious to some, but I’ll make them clear shortly anyway.

However, when it comes to investing, I’m in the business of building wealth, and not necessarily following the crowd.

Here’s why I’d be willing to buy some British American Tobacco shares as soon as I have some investable funds.

Health consciousness

It seems the world has awoken from a slumber in recent years and realised smoking is bad for your health. What a shock that is! Anyway, when you couple that with the rise of ESG investing, tobacco firms like British American are now being shunned by many.

The world’s governments are leading the charge to try and dissuade people from smoking, and are pushing hard. There are also constant threats of law changes that could ban the purchasing of certain tobacco products.

Both of these issues are ongoing risks that could dent British American’s earnings and returns, and something I’ll keep an eye on.

With the changing shift in sentiment in recent years, it’s no wonder the shares have struggled. For context, British American shares are down just 5% over a 12-month period from 2,603p at this time last year, to current levels of 2,457p. Not bad, right? Well, looking back further, they’re down 55% over a seven year period from 5,530p, to current levels.

Dividend king!

With my goal of building wealth, it’s hard to ignore the passive income opportunity that British American Tobacco offers, as well as its past track record. Although I understand that past performance is not an indicator of the future, the business has raised its dividend for years now. I can’t see that slowing anytime soon.

At present, the shares offer a dividend yield of 9.4%. For context, the FTSE 100 average is 3.8%. However, I do understand that dividends are never guaranteed. Plus, the shares trade on a rock-bottom valuation, with a price-to-earnings ratio of just six.

With low cost, high prices, and such strong brand power, as well as humongous reach, it’s not hard to understand why the tobacco giant has been a dividend-seekers’ favourite in the past. It still is to many at present as well.

But what about the threat of increased regulation? Well, in my view, such regulation could take a long time to come to fruition. By this, I mean the type of timescale that could allow me to bag plenty of dividends. We’re talking years, if not decades.

Furthermore, British American is realising the need to pivot its approach due to the threat of bans. Its alternative tobacco products seem to be flying off the shelf. This new revenue stream could continue to support earnings and generous returns too.

To summarise, the fundamentals and passive income opportunity, look enticing. The threats are credible, but the opportunity to build wealth through dividends is too attractive to miss out to me.

Sumayya Mansoor has no position in any of the shares mentioned. The Motley Fool UK has recommended British American Tobacco P.l.c. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »